Discover the latest advancements in hereditary angioedema HAE management from the 2024 ACAAI Annual Scientific Meeting highlighting promising data on new oral treatments like sebetralstat and deucrictibant These therapies offer faster more accessible options for acute HAE attack relief supporting improved patient independence and adherence
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/internal-medicine/acute-management-in-hae/30557-63867
- Start Date: 2024-11-22 06:00:00
- End Date: 2024-11-22 06:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours - Commercial Support: Source: Ionis Pharmaceuticals Inc - Amount: 18750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest